Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Study

NCT07045142 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT07045142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07045142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Study
Lead sponsor
Central South University
Phase
Phase 3
Overall status
Recruiting
Start date
July 1, 2025
Completion date
June 1, 2028
Enrollment
400 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia